by Marie Gethins
With weak pharmaceutical product pipelines and demand increasing for tailored medical approaches, human adult stem cells (ASCs) and embryonic stem...
Stem Cell Therapies: Excitement Builds but Challenges Remain
With weak pharmaceutical pipelines and demand increasing for tailored medical approaches, adult and embryonic stem cell therapies are gaining ground as a therapeutic focus. Numerous companies are now active in this research and some observers estimate that the stem cell market could reach between $8.5 and $10 billion within the next ten years.